186 related articles for article (PubMed ID: 31424670)
1. Serum miR-1301-3p, miR-335-5p, miR-28-5p, and their target B7-H3 may serve as novel biomarkers for colorectal cancer.
Wang L; Zhao Y; Xu M; Zhou F; Yan J
J BUON; 2019; 24(3):1120-1127. PubMed ID: 31424670
[TBL] [Abstract][Full Text] [Related]
2. B7-H3, Negatively Regulated by miR-128, Promotes Colorectal Cancer Cell Proliferation and Migration.
Hu X; Xu M; Hu Y; Li N; Zhou L
Cell Biochem Biophys; 2021 Jun; 79(2):397-405. PubMed ID: 33743142
[TBL] [Abstract][Full Text] [Related]
3. Expression levels of miR-143-3p and -424-5p in colorectal cancer and their clinical significance.
Sahami-Fard MH; Kheirandish S; Sheikhha MH
Cancer Biomark; 2019; 24(3):291-297. PubMed ID: 30883340
[TBL] [Abstract][Full Text] [Related]
4. The expression and clinical significance of B7-H3 and miR-145 in lung cancer patients with malignant pleural effusion.
Huang L
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6759-6766. PubMed ID: 32633367
[TBL] [Abstract][Full Text] [Related]
5. Clinical correlation of B7-H3 and B3GALT4 with the prognosis of colorectal cancer.
Zhang T; Wang F; Wu JY; Qiu ZC; Wang Y; Liu F; Ge XS; Qi XW; Mao Y; Hua D
World J Gastroenterol; 2018 Aug; 24(31):3538-3546. PubMed ID: 30131660
[TBL] [Abstract][Full Text] [Related]
6. MTUS1 and its targeting miRNAs in colorectal carcinoma: significant associations.
Ozcan O; Kara M; Yumrutas O; Bozgeyik E; Bozgeyik I; Celik OI
Tumour Biol; 2016 May; 37(5):6637-45. PubMed ID: 26643896
[TBL] [Abstract][Full Text] [Related]
7. Identifying microRNAs regulating B7-H3 in breast cancer: the clinical impact of microRNA-29c.
Nygren MK; Tekle C; Ingebrigtsen VA; Mäkelä R; Krohn M; Aure MR; Nunes-Xavier CE; Perälä M; Tramm T; Alsner J; Overgaard J; Nesland JM; Borgen E; Børresen-Dale AL; Fodstad Ø; Sahlberg KK; Leivonen SK
Br J Cancer; 2014 Apr; 110(8):2072-80. PubMed ID: 24577056
[TBL] [Abstract][Full Text] [Related]
8. Tissue miR-200c-3p and circulating miR-1290 as potential prognostic biomarkers for colorectal cancer.
Kang E; Jung SC; Nam SK; Park Y; Seo SH; Park KU; Oh HK; Kim DW; Kang SB; Lee HS
Sci Rep; 2022 Feb; 12(1):2295. PubMed ID: 35145164
[TBL] [Abstract][Full Text] [Related]
9. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.
Zhang H; Zhu M; Shan X; Zhou X; Wang T; Zhang J; Tao J; Cheng W; Chen G; Li J; Liu P; Wang Q; Zhu W
Gene; 2019 Mar; 687():246-254. PubMed ID: 30458288
[TBL] [Abstract][Full Text] [Related]
10. Colorectal cancer cell-derived extracellular vesicles transfer miR-221-3p to promote endothelial cell angiogenesis via targeting suppressor of cytokine signaling 3.
Dokhanchi M; Pakravan K; Zareian S; Hussen BM; Farid M; Razmara E; Mossahebi-Mohammadi M; Cho WC; Babashah S
Life Sci; 2021 Nov; 285():119937. PubMed ID: 34508764
[TBL] [Abstract][Full Text] [Related]
11. Clinical and biological significance of miR-378a-3p and miR-378a-5p in colorectal cancer.
Li H; Dai S; Zhen T; Shi H; Zhang F; Yang Y; Kang L; Liang Y; Han A
Eur J Cancer; 2014 Apr; 50(6):1207-21. PubMed ID: 24412052
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of B7-H3 in CD133+ colorectal cancer cells is associated with cancer progression and survival in human patients.
Bin Z; Guangbo Z; Yan G; Huan Z; Desheng L; Xueguang Z
J Surg Res; 2014 May; 188(2):396-403. PubMed ID: 24630518
[TBL] [Abstract][Full Text] [Related]
13. MiRNAs as molecular biomarkers in stage II egyptian colorectal cancer patients.
Bahnassy AA; Salem SE; El-Sayed M; Khorshid O; Abdellateif MS; Youssef AS; Mohanad M; Hussein M; Zekri AN; Ali NM
Exp Mol Pathol; 2018 Dec; 105(3):260-271. PubMed ID: 30213464
[TBL] [Abstract][Full Text] [Related]
14. miR-34a induces immunosuppression in colorectal carcinoma through modulating a SIRT1/NF-κB/B7-H3/TNF-α axis.
Meng F; Yang M; Chen Y; Chen W; Wang W
Cancer Immunol Immunother; 2021 Aug; 70(8):2247-2259. PubMed ID: 33492448
[TBL] [Abstract][Full Text] [Related]
15. The distinct role of strand-specific miR-514b-3p and miR-514b-5p in colorectal cancer metastasis.
Ren LL; Yan TT; Shen CQ; Tang JY; Kong X; Wang YC; Chen J; Liu Q; He J; Zhong M; Chen HY; Hong J; Fang JY
Cell Death Dis; 2018 Jun; 9(6):687. PubMed ID: 29880874
[TBL] [Abstract][Full Text] [Related]
16. Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma.
Fang Z; Tang J; Bai Y; Lin H; You H; Jin H; Lin L; You P; Li J; Dai Z; Liang X; Su Y; Hu Q; Wang F; Zhang ZY
J Exp Clin Cancer Res; 2015 Aug; 34(1):86. PubMed ID: 26297223
[TBL] [Abstract][Full Text] [Related]
17. Expression Analysis of Previously Verified Fecal and Plasma Dow-regulated MicroRNAs (miR-4478, 1295-3p, 142-3p and 26a-5p), in FFPE Tissue Samples of CRC Patients.
Ghanbari R; Rezasoltani S; Hashemi J; Mohamadkhani A; Tahmasebifar A; Arefian E; Mobarra N; Asadi J; Nazemalhosseini Mojarad E; Yazdani Y; Knuutila S; Malekzadeh R
Arch Iran Med; 2017 Feb; 20(2):92-95. PubMed ID: 28193082
[TBL] [Abstract][Full Text] [Related]
18. The tumor suppressor miR-138-5p targets PD-L1 in colorectal cancer.
Zhao L; Yu H; Yi S; Peng X; Su P; Xiao Z; Liu R; Tang A; Li X; Liu F; Shen S
Oncotarget; 2016 Jul; 7(29):45370-45384. PubMed ID: 27248318
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA miR-29a Inhibits Colon Cancer Progression by Downregulating B7-H3 Expression: Potential Molecular Targets for Colon Cancer Therapy.
Wang J; Chen X; Xie C; Sun M; Hu C; Zhang Z; Luan L; Zhou J; Zhou J; Zhu X; Ouyang J; Dong X; Li D; Zhang J; Zhao X
Mol Biotechnol; 2021 Sep; 63(9):849-861. PubMed ID: 34100183
[TBL] [Abstract][Full Text] [Related]
20. Serum microRNA-135a-5p as an auxiliary diagnostic biomarker for colorectal cancer.
Wang Q; Zhang H; Shen X; Ju S
Ann Clin Biochem; 2017 Jan; 54(1):76-85. PubMed ID: 27126269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]